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Several independent studies have reported asso-
ciation between serotonin transporter gene
(SLC6A4) polymorphisms and attention deficit
hyperactivity disorder (ADHD). Five studies
found evidence for association between the long-
allele of a 44-bp insertion/deletion polymorphism
(5-HTTLPR) and ADHD. Another two studies cor-
roborated this finding while a further six studies
did not find such an association. For a second
polymorphism within the gene, a variable number
tandem repeat (VNTR) within intron 2, one study
demonstrated that the 12/12 genotype was signifi-
cantly less frequent in ADHD cases compared to
controls, while a second study found that the 12-
allele was preferentially transmitted to offspring
affected with ADHD. To provide further clarifica-
tion of the reported associations, we investigated
the association of these two markers with ADHD
in a sample of 1,020 families with 1,166 combined
type ADHD cases for the International Multi-
Centre ADHD Genetics project, using the Trans-
mission Disequilibrium Test. Given the large body
of work supporting the association of the promo-
ter polymorphism and mood disorders, we further
analyzed the group of subjects with ADHD plus
mood disorder separately. No association was
found between either of the two markers and
ADHD in our large multisite study or with
depression within the sample of ADHD cases.
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The human serotonin transporter gene (SLC6A4, formerly
known as 5-HTT) is located at chromosome 17q11.2-12. Two
common polymorphisms within the gene have been described:
a 44-bp insertion/deletion in the promoter region (5-HTTLPR)
[Heils et al., 1996] and a variable number tandem repeat in
intron 2 (STin2-VNTR) [Lesch et al., 1994]. Several research
groups have studied the association between these SLC6A4
polymorphisms and attention deficit hyperactivity disorder
(ADHD). Five studies found evidence for association between
the long-allele of the 5-HTTLPR polymorphism and ADHD or
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closely related phenotypes [Seeger et al., 2001; Kent et al.,
2002; Retz et al., 2002; Beitchman et al., 2003; Curran et al.,
2005]. In accord with these data two other studies found that
short/short genotype was significantly underrepresented in
children with ADHD compared to controls [Manor et al., 2001;
Zorog˘lu et al., 2002]. However, Li et al. [2007] reported a
preferential transmission of the short-allele to ADHD offspring
in a Chinese sample and six further studies did not find any
association between the polymorphism and ADHD [Langley
et al., 2003; Kim et al., 2005; Xu et al., 2005; Banerjee et al.,
2006; Wigg et al., 2006; Heiser et al., 2007]. A study that
combined the available data by pooling odds ratios across
studies found a small but significant association of the long
allele of 5-HTTLPR with ADHD [Faraone et al., 2005].
For the STin2-VNTR marker one study found that the 12/12
genotype was significantly less frequent in ADHD cases
compared to controls [Zorog˘lu et al., 2002], while another
study found that the 12-repeat allele was preferentially over-
transmitted to ADHD offspring [Banerjee et al., 2006]. A
further seven studies did not demonstrate an association
between STin2-VNTR and ADHD [Kent et al., 2002; Langley
et al., 2003; Curran et al., 2005; Kim et al., 2005; Xu et al., 2005;
Heiser et al., 2007; Li et al., 2007].
The aim of this study was to further investigate the
relationship between these two polymorphisms of SLC6A4
(in particular the association with 5-HTTLPR that was found
to be associated with ADHD following meta-analysis) using a
large sample of combined type ADHD cases collected by the
International Multi-Centre ADHD Genetics (IMAGE) project.
In addition because there is strong evidence that short allele of
5-HTTLPR is associated with symptoms of depression, prob-
ably by modifying environmental risks [Furlong et al., 1998;
Canli and Lesch, 2007], we further investigated whether the
short allele was over-transmitted to the group of children with
ADHD comorbid with significant mood symptoms. The hypoth-
esis tested being that aspects of ADHD would act as an
environmental stressor, increasing the chances of developing
depressive symptoms in the presence of the short allele of 5-
HTTLPR.
European Caucasian subjects were recruited from 11
specialist clinics in 8 countries: Belgium, Germany, Holland,
Ireland, Israel, Spain, Switzerland, and United Kingdom.
Ethical approval for this study was obtained from National
Institute of Health registered ethical review boards for each
center. Detailed information sheets were provided and
informed consent obtained from children and their parents.
All ADHD probands and their siblings were aged 5–17 at
the time of entry into the study and access was required to one
or both biological parents for DNA collection. Entry criteria for
probands were a clinical diagnosis of DSM-IV combined
subtype ADHD, having one or more full siblings available for
ascertainment of clinical information and DNA collection.
Exclusion criteria applying to both probands and siblings
include autism, epilepsy, IQ< 70, brain disorders and any
genetic or medical disorder associated with externalizing
behaviors that might mimic ADHD.
All raw data were centralized and stored on a secure
database at the MRC Social Genetic Developmental Psychia-
try research center in London. The diagnosis of ADHD was
made following a parent interview with the Parental Account
of Child Symptoms interview [PACS; Taylor et al., 1986] that
asks about ADHD symptoms in various settings. An algo-
rithm was used to derive each of the DSM-IV ADHD
symptoms from the PACS interview data and these were
combined with items that scored two or more from teacher
ratings of DSM-IV items taken from the long version of the
Conners’ Teacher Rating Scale [Conners, 1995]. The diag-
nosis of ADHD was made if sufficient items were identified to
fulfill DSM-IV criteria, and both impairment (based on
severity of symptoms identified in the PACS interview) and
pervasiveness (based on the presence of ADHD symptoms in
more than one setting from PACS and scoring more than one
item on the teacher Conners) were present. In a few cases
where no Conners data were present pervasiveness was
defined on the basis of PACS data alone.
The PACS interview was also used to identify the group of
ADHD cases with a possible mood disorder. Although PACS
does not formally generate DSM-IV diagnostic categories for
mood disorders, it identifies individuals reporting high and
impairing levels of mood symptoms. The key criteria for
depression were the presence of marked misery lasting more
than 6 hr during which time the child could only be cheered up
with difficulty, on 3–6 days a week, or the presence of severe
misery (could not be cheered up at all), on at least 1 or 2 days
a week. Similar frequency criteria applied for other changes in
mood that were either marked (showing diminished interest or
pleasure in activities, or marked lack of energy and fatigue,
lasting 6 hr or more) or severe (no engagement even in
normally pleasurable activities).
The final dataset used in this study consisted of 1,020 ADHD
families with 1,166 DSM-IV combined type probands. Of these
there were 199 ADHD cases (15% of the cases) with evidence of
a comorbid mood disorder from the PACS interview data. DNA
was available for both parents in 891 families (87%) and from
one parent in 129 families (13%). Eighty-eight percentage of
the ADHD cases were male.
Genotyping followed routine procedures. The 44-bp inser-
tion/deletion 5-HTTLPR polymorphism and the 17-bp STin2-
VNTR polymorphism were genotyped using the methods
described in Zorog˘lu et al. [2002]. The program suite
UNPHASED was used to test the linkage disequilibrium
(LD) between the individual marker locus and haplotypes
[Dudbridge, 2003]. TDTPHASE was used for the transmission
disequilibrium test (TDT) analysis from family genotype data.
In total we obtained data from 1,166 affected children for the
two polymorphisms located in the SLC6A4 gene. We found no
evidence for the preferential transmission of the long-allele of
5-HTTLPR to affected offspring as previously reported, and
also no evidence of biased transmission of the short-allele
(Table I). For STin2-VNTR, three alleles (9-repeat, 10-repeat,
and 12-repeat) were detected in our sample with the most
common alleles being the 10-repeat and 12-repeat alleles. The
TABLE I. Results of the TDT Analysis of 5-HTTLPR and STin2-VNTR Polymorphisms
Polymorphism Allele Transmitted Non-transmitted w2 P-value OR
5-HTTLPR L 496 462 1.21 0.27 1.07
S 462 496 1.21 0.27 0.93
STin2-VNTR 9 25 25 0.00 1.00 1.00
10 462 452 0.11 0.74 1.02
12 463 473 0.11 0.74 0.98
5-HTTLPR likelihood ratio test: null¼664.0, alternative¼663.4, LRS¼ 1.207, df¼ 1, P¼0.272.
STin2-VNTR likelihood ratio test: null¼658.5, alternative¼658.4, LRS¼ 0.110, df¼ 2, P¼0.947.
The degrees of freedom for the allele-specific test is 1.
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common alleles were not significantly associated with ADHD
in this sample (Table I).
We also found no evidence of over-transmission of the 5-
HTTLPR risk allele for depression, in the sub-group with
ADHD plus evidence of a mood disorder (w2¼ 1.9, P¼ 0.17 for 5-
HTTLPR; w2¼ 2.4). Similarly there was no evidence of
association with the intron 2 markers in this group (P¼ 0.30
for STin2-VNTR), nor in the group with ADHD with no
evidence of a comorbid mood problem with either marker
(w2¼ 0.74, P¼ 0.39 for 5-HTTLPR; w2¼ 0.05, P¼ 0.97 for
STin2-VNTR). LD between the two polymorphisms was
significant but moderate using the D0 and r2 statistic
(D0 ¼ 0.42, r2¼ 0.29). There was no evidence of biased trans-
mission of any of the haplotypes (Table II).
In summary, we investigated the relationship between
ADHD and two SLC6A4 polymorphisms that had previously
been reported to be associated with ADHD. Our large multisite
study of 1,166 combined type probands found no evidence for an
association with either of the two polymorphisms. Given the
large body of work supporting the association of the promoter
polymorphism and mood disorders [Canli and Lesch, 2007] we
analyzed the group of subjects with ADHD plus mood disorder
separately, but also found no evidence for association. Formal
meta-analysis of these with other available datasets is now
required to clarify whether the serotonin transporter gene has
an aetiological role in ADHD susceptibility.
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